Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Van Der Meeren, Olivier; Hatherill, Mark; Nduba, Videlis; Wilkinson, Robert J; Muyoyeta, Monde; Van Brakel, Elana; Ayles, Helen M; Henostroza, German; Thienemann, Friedrich; Scriba, Thomas J; +16 more... Diacon, Andreas; Blatner, Gretta L; Demoitié, Marie-Ange; Tameris, Michele; Malahleha, Mookho; Innes, James C; Hellström, Elizabeth; Martinson, Neil; Singh, Tina; Akite, Elaine J; Khatoon Azam, Aisha; Bollaerts, Anne; Ginsberg, Ann M; Evans, Thomas G; Gillard, Paul; Tait, Dereck R; (2018) Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. The New England journal of medicine, 379 (17). pp. 1621-1634. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa1803484

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa1803484

Abstract

Share

Download

Filename: Van-Der-Meeren_etal_2018_Phase-2b-Controlled-Trial-of-M72-AS01E-Vaccine-to-Prevent-Tuberculosis.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar